目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 18: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 21: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 22: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 23: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration
5.1 Market segments
Exhibit 25: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibit 26: Data Table on Route of Administration - Market share 2021-2026 (%)
5.2 Comparison by Route of Administration
Exhibit 27: Chart on Comparison by Route of Administration
Exhibit 28: Data Table on Comparison by Route of Administration
5.3 Oral - Market size and forecast 2021-2026
Exhibit 29: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibit 31: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibit 32: Data Table on Oral - Year-over-year growth 2021-2026 (%)
5.4 Topical - Market size and forecast 2021-2026
Exhibit 33: Chart on Topical - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
Exhibit 35: Chart on Topical - Year-over-year growth 2021-2026 (%)
Exhibit 36: Data Table on Topical - Year-over-year growth 2021-2026 (%)
5.5 Market opportunity by Route of Administration
Exhibit 37: Market opportunity by Route of Administration ($ million)

6 Market Segmentation by Drug Class
6.1 Market segments
Exhibit 38: Chart on Drug Class - Market share 2021-2026 (%)
Exhibit 39: Data Table on Drug Class - Market share 2021-2026 (%)
6.2 Comparison by Drug Class
Exhibit 40: Chart on Comparison by Drug Class
Exhibit 41: Data Table on Comparison by Drug Class
6.3 SSRIs - Market size and forecast 2021-2026
Exhibit 42: Chart on SSRIs - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on SSRIs - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on SSRIs - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on SSRIs - Year-over-year growth 2021-2026 (%)
6.4 PDE5 inhibitors - Market size and forecast 2021-2026
Exhibit 46: Chart on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
6.5 Amide anesthetics - Market size and forecast 2021-2026
Exhibit 50: Chart on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Amide anesthetics - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Amide anesthetics - Year-over-year growth 2021-2026 (%)
6.6 Others - Market size and forecast 2021-2026
Exhibit 54: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Others - Year-over-year growth 2021-2026 (%)
6.7 Market opportunity by Drug Class
Exhibit 58: Market opportunity by Drug Class ($ million)

7 Customer Landscape
7.1 Customer landscape overview
Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape
8.1 Geographic segmentation
Exhibit 60: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
8.2 Geographic comparison
Exhibit 62: Chart on Geographic comparison
Exhibit 63: Data Table on Geographic comparison
8.3 North America - Market size and forecast 2021-2026
Exhibit 64: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 66: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 67: Data Table on North America - Year-over-year growth 2021-2026 (%)
8.4 Europe - Market size and forecast 2021-2026
Exhibit 68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 70: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 71: Data Table on Europe - Year-over-year growth 2021-2026 (%)
8.5 Asia - Market size and forecast 2021-2026
Exhibit 72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 74: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 75: Data Table on Asia - Year-over-year growth 2021-2026 (%)
8.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
8.7 US - Market size and forecast 2021-2026
Exhibit 80: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 81: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 82: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 83: Data Table on US - Year-over-year growth 2021-2026 (%)
8.8 Italy - Market size and forecast 2021-2026
Exhibit 84: Chart on Italy - Market size and forecast 2021-2026 ($ million)
Exhibit 85: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
Exhibit 86: Chart on Italy - Year-over-year growth 2021-2026 (%)
Exhibit 87: Data Table on Italy - Year-over-year growth 2021-2026 (%)
8.9 China - Market size and forecast 2021-2026
Exhibit 88: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 89: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 90: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 91: Data Table on China - Year-over-year growth 2021-2026 (%)
8.10 UK - Market size and forecast 2021-2026
Exhibit 92: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 93: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 94: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 95: Data Table on UK - Year-over-year growth 2021-2026 (%)
8.11 India - Market size and forecast 2021-2026
Exhibit 96: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibit 97: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibit 98: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibit 99: Data Table on India - Year-over-year growth 2021-2026 (%)
8.12 Market opportunity By Geographical Landscape
Exhibit 100: Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Trends
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2021 and 2026
9.4 Market trends

10 Vendor Landscape
10.1 Overview
10.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
10.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
10.4 Industry risks
Exhibit 104: Impact of key risks on business

11 Vendor Analysis
11.1 Vendors covered
Exhibit 105: Vendors covered
11.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
11.3 Absorption Pharmaceuticals LLC
Exhibit 107: Absorption Pharmaceuticals LLC - Overview
Exhibit 108: Absorption Pharmaceuticals LLC - Product / Service
Exhibit 109: Absorption Pharmaceuticals LLC - Key offerings
11.4 Alembic Pharmaceuticals Inc.
Exhibit 110: Alembic Pharmaceuticals Inc. - Overview
Exhibit 111: Alembic Pharmaceuticals Inc. - Product / Service
Exhibit 112: Alembic Pharmaceuticals Inc. - Key offerings
11.5 Amneal Pharmaceuticals Inc.
Exhibit 113: Amneal Pharmaceuticals Inc. - Overview
Exhibit 114: Amneal Pharmaceuticals Inc. - Business segments
Exhibit 115: Amneal Pharmaceuticals Inc. - Key news
Exhibit 116: Amneal Pharmaceuticals Inc. - Key offerings
Exhibit 117: Amneal Pharmaceuticals Inc. - Segment focus
11.6 Bayer AG
Exhibit 118: Bayer AG - Overview
Exhibit 119: Bayer AG - Business segments
Exhibit 120: Bayer AG - Key offerings
Exhibit 121: Bayer AG - Segment focus
11.7 Cipla Ltd.
Exhibit 122: Cipla Ltd. - Overview
Exhibit 123: Cipla Ltd. - Business segments
Exhibit 124: Cipla Ltd. - Key news
Exhibit 125: Cipla Ltd. - Key offerings
Exhibit 126: Cipla Ltd. - Segment focus
11.8 Eli Lilly and Co.
Exhibit 127: Eli Lilly and Co. - Overview
Exhibit 128: Eli Lilly and Co. - Product / Service
Exhibit 129: Eli Lilly and Co. - Key offerings
11.9 Pfizer Inc.
Exhibit 130: Pfizer Inc. - Overview
Exhibit 131: Pfizer Inc. - Product / Service
Exhibit 132: Pfizer Inc. - Key news
Exhibit 133: Pfizer Inc. - Key offerings
11.10 Sandoz International GmbH
Exhibit 134: Sandoz International GmbH - Overview
Exhibit 135: Sandoz International GmbH - Product / Service
Exhibit 136: Sandoz International GmbH - Key news
Exhibit 137: Sandoz International GmbH - Key offerings
11.11 Solco Healthcare
Exhibit 138: Solco Healthcare - Overview
Exhibit 139: Solco Healthcare - Product / Service
Exhibit 140: Solco Healthcare - Key offerings
11.12 Teva Pharmaceutical Industries Ltd.
Exhibit 141: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 142: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 143: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 144: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 145: Teva Pharmaceutical Industries Ltd. - Segment focus

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Exhibit 146: Inclusions checklist
Exhibit 147: Exclusions checklist
12.3 Currency conversion rates for US$
Exhibit 148: Currency conversion rates for US$
12.4 Research methodology
Exhibit 149: Research methodology
Exhibit 150: Validation techniques employed for market sizing
Exhibit 151: Information sources
12.5 List of abbreviations
Exhibit 152: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits18: Five forces analysis - Comparison between 2021 and 2026
Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits20: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits21: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits22: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits23: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits24: Chart on Market condition - Five forces 2021 and 2026
Exhibits25: Chart on Route of Administration - Market share 2021-2026 (%)
Exhibits26: Data Table on Route of Administration - Market share 2021-2026 (%)
Exhibits27: Chart on Comparison by Route of Administration
Exhibits28: Data Table on Comparison by Route of Administration
Exhibits29: Chart on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits30: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
Exhibits31: Chart on Oral - Year-over-year growth 2021-2026 (%)
Exhibits32: Data Table on Oral - Year-over-year growth 2021-2026 (%)
Exhibits33: Chart on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits34: Data Table on Topical - Market size and forecast 2021-2026 ($ million)
Exhibits35: Chart on Topical - Year-over-year growth 2021-2026 (%)
Exhibits36: Data Table on Topical - Year-over-year growth 2021-2026 (%)
Exhibits37: Market opportunity by Route of Administration ($ million)
Exhibits38: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits39: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits40: Chart on Comparison by Drug Class
Exhibits41: Data Table on Comparison by Drug Class
Exhibits42: Chart on SSRIs - Market size and forecast 2021-2026 ($ million)
Exhibits43: Data Table on SSRIs - Market size and forecast 2021-2026 ($ million)
Exhibits44: Chart on SSRIs - Year-over-year growth 2021-2026 (%)
Exhibits45: Data Table on SSRIs - Year-over-year growth 2021-2026 (%)
Exhibits46: Chart on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on PDE5 inhibitors - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on PDE5 inhibitors - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Amide anesthetics - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Amide anesthetics - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Amide anesthetics - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits58: Market opportunity by Drug Class ($ million)
Exhibits59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits60: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits61: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits62: Chart on Geographic comparison
Exhibits63: Data Table on Geographic comparison
Exhibits64: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits66: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits67: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits70: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits71: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits74: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits75: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits80: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits81: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits82: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits83: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits84: Chart on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits85: Data Table on Italy - Market size and forecast 2021-2026 ($ million)
Exhibits86: Chart on Italy - Year-over-year growth 2021-2026 (%)
Exhibits87: Data Table on Italy - Year-over-year growth 2021-2026 (%)
Exhibits88: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits89: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits90: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits91: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits92: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits93: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits94: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits95: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits96: Chart on India - Market size and forecast 2021-2026 ($ million)
Exhibits97: Data Table on India - Market size and forecast 2021-2026 ($ million)
Exhibits98: Chart on India - Year-over-year growth 2021-2026 (%)
Exhibits99: Data Table on India - Year-over-year growth 2021-2026 (%)
Exhibits100: Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2021 and 2026
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Absorption Pharmaceuticals LLC - Overview
Exhibits108: Absorption Pharmaceuticals LLC - Product / Service
Exhibits109: Absorption Pharmaceuticals LLC - Key offerings
Exhibits110: Alembic Pharmaceuticals Inc. - Overview
Exhibits111: Alembic Pharmaceuticals Inc. - Product / Service
Exhibits112: Alembic Pharmaceuticals Inc. - Key offerings
Exhibits113: Amneal Pharmaceuticals Inc. - Overview
Exhibits114: Amneal Pharmaceuticals Inc. - Business segments
Exhibits115: Amneal Pharmaceuticals Inc. - Key news
Exhibits116: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits117: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits118: Bayer AG - Overview
Exhibits119: Bayer AG - Business segments
Exhibits120: Bayer AG - Key offerings
Exhibits121: Bayer AG - Segment focus
Exhibits122: Cipla Ltd. - Overview
Exhibits123: Cipla Ltd. - Business segments
Exhibits124: Cipla Ltd. - Key news
Exhibits125: Cipla Ltd. - Key offerings
Exhibits126: Cipla Ltd. - Segment focus
Exhibits127: Eli Lilly and Co. - Overview
Exhibits128: Eli Lilly and Co. - Product / Service
Exhibits129: Eli Lilly and Co. - Key offerings
Exhibits130: Pfizer Inc. - Overview
Exhibits131: Pfizer Inc. - Product / Service
Exhibits132: Pfizer Inc. - Key news
Exhibits133: Pfizer Inc. - Key offerings
Exhibits134: Sandoz International GmbH - Overview
Exhibits135: Sandoz International GmbH - Product / Service
Exhibits136: Sandoz International GmbH - Key news
Exhibits137: Sandoz International GmbH - Key offerings
Exhibits138: Solco Healthcare - Overview
Exhibits139: Solco Healthcare - Product / Service
Exhibits140: Solco Healthcare - Key offerings
Exhibits141: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits142: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits143: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits144: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits145: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits146: Inclusions checklist
Exhibits147: Exclusions checklist
Exhibits148: Currency conversion rates for US$
Exhibits149: Research methodology
Exhibits150: Validation techniques employed for market sizing
Exhibits151: Information sources
Exhibits152: List of abbreviations